See more : United Oil & Gas Plc (UOG.L) Income Statement Analysis – Financial Results
Complete financial analysis of The Joint Corp. (JYNT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Joint Corp., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- KP Tissue Inc. (KPT.TO) Income Statement Analysis – Financial Results
- Shandong Liancheng Precision Manufacturing Co., Ltd (002921.SZ) Income Statement Analysis – Financial Results
- Apollo Strategic Growth Capital II (APGB) Income Statement Analysis – Financial Results
- Hareket Proje Tasimaciligi ve Yuk Muhendisligi Anonim Sirketi (HRKET.IS) Income Statement Analysis – Financial Results
- Starrex International Ltd. (STXMF) Income Statement Analysis – Financial Results
The Joint Corp. (JYNT)
About The Joint Corp.
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 117.70M | 101.91M | 81.19M | 58.68M | 48.45M | 31.79M | 25.16M | 20.52M | 13.84M | 7.12M | 5.96M | 2.78M |
| Cost of Revenue | 10.55M | 9.83M | 8.51M | 6.51M | 5.57M | 4.31M | 3.31M | 2.94M | 2.82M | 2.25M | 2.01M | 1.09M |
| Gross Profit | 107.15M | 92.08M | 72.68M | 52.18M | 42.88M | 27.48M | 21.85M | 17.58M | 11.02M | 4.87M | 3.95M | 1.69M |
| Gross Profit Ratio | 91.04% | 90.35% | 89.51% | 88.91% | 88.51% | 86.44% | 86.84% | 85.68% | 79.62% | 68.43% | 66.33% | 60.84% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 343.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 81.47M | 67.99M | 49.12M | 36.20M | 30.54M | 20.30M | 18.12M | 22.10M | 15.37M | 5.10M | 2.66M | 2.24M |
| Selling & Marketing | 16.54M | 13.96M | 11.42M | 7.80M | 6.91M | 4.82M | 4.47M | 4.42M | 3.69M | 1.19M | 781.26K | 748.92K |
| SG&A | 98.01M | 81.95M | 60.55M | 44.00M | 37.46M | 25.12M | 22.59M | 26.52M | 19.06M | 6.29M | 3.44M | 2.99M |
| Other Expenses | 11.21M | 7.64M | 6.09M | 2.73M | 1.90M | -47.77K | -64.46K | 13.30K | 22.12K | -64.08K | -32.00K | 36.32K |
| Operating Expenses | 109.22M | 89.59M | 66.64M | 46.73M | 39.36M | 26.68M | 24.61M | 29.09M | 20.33M | 6.50M | 3.51M | 3.04M |
| Cost & Expenses | 119.77M | 99.42M | 75.15M | 53.24M | 44.92M | 30.99M | 27.92M | 32.03M | 23.15M | 8.74M | 5.52M | 4.13M |
| Interest Income | 0.00 | 133.10K | 69.88K | 79.48K | 61.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 67.46K | 953.53K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 8.58M | 6.65M | 6.09M | 2.73M | 1.90M | 1.56M | 2.02M | 2.57M | 1.27M | 210.12K | 70.73K | 49.81K |
| EBITDA | 9.14M | 7.89M | 12.16M | 8.18M | 5.43M | 2.29M | -896.78K | -8.85M | -7.76M | -1.42M | 510.51K | -1.30M |
| EBITDA Ratio | 7.77% | 10.34% | 14.98% | 13.84% | 11.40% | 9.10% | -1.28% | -26.39% | -60.05% | -19.91% | 8.57% | -46.58% |
| Operating Income | -2.07M | 2.90M | 6.01M | 5.49M | 3.41M | 205.11K | -3.17M | -15.02M | -9.32M | -1.63M | 439.79K | -1.35M |
| Operating Income Ratio | -1.76% | 2.84% | 7.40% | 9.36% | 7.05% | 0.65% | -12.62% | -73.20% | -67.34% | -22.86% | 7.38% | -48.37% |
| Total Other Income/Expenses | 3.71M | -133.10K | -187.33K | -79.48K | -42.22K | -33.59K | -64.46K | -1.47K | 283.27K | -64.08K | -32.00K | 36.32K |
| Income Before Tax | 1.64M | 1.94M | 5.94M | 5.41M | 3.37M | 215.36K | -3.24M | -15.01M | -9.03M | -1.69M | 407.79K | -1.31M |
| Income Before Tax Ratio | 1.39% | 1.91% | 7.31% | 9.22% | 6.96% | 0.68% | -12.87% | -73.13% | -65.29% | -23.76% | 6.84% | -47.07% |
| Income Tax Expense | 11.39M | 766.51K | -1.22M | -7.75M | 48.71K | -37.73K | 35.88K | 164.43K | -235.86K | 1.34M | 252.15K | -574.53K |
| Net Income | -9.75M | 1.18M | 7.57M | 13.17M | 3.32M | 253.08K | -3.28M | -15.17M | -8.80M | -3.03M | 155.64K | -736.30K |
| Net Income Ratio | -8.29% | 1.16% | 9.32% | 22.44% | 6.86% | 0.80% | -13.02% | -73.93% | -63.59% | -42.59% | 2.61% | -26.44% |
| EPS | -0.66 | 0.08 | 0.46 | 0.94 | 0.24 | 0.02 | -0.25 | -1.20 | -0.88 | -0.56 | 0.02 | -0.08 |
| EPS Diluted | -0.66 | 0.08 | 0.44 | 0.90 | 0.23 | 0.02 | -0.25 | -1.20 | -0.88 | -0.56 | 0.02 | -0.08 |
| Weighted Avg Shares Out | 14.69M | 14.49M | 14.32M | 14.00M | 13.82M | 13.67M | 13.20M | 12.64M | 10.00M | 5.41M | 9.17M | 9.17M |
| Weighted Avg Shares Out (Dil) | 14.69M | 14.87M | 14.94M | 14.58M | 14.47M | 14.03M | 13.25M | 12.70M | 10.04M | 5.45M | 9.17M | 9.17M |
The Joint Corp. (JYNT) Q3 Earnings Match Estimates
The Joint Corp. (JYNT) came out with quarterly earnings of $0.04 per share, in line with the Zacks Consensus Estimate. This compares to loss of $0.05 per share a year ago.
LiqTech Establishes a Joint Venture in China for Marine Water Treatment Market
BALLERUP, Denmark , Nov. 7, 2024 /PRNewswire/ -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, and Jiangsu Marine Equipment Co., Ltd. ("JiTRI"), have established a joint venture ("JV")...
Gold Fields and AngloGold Ashanti Provide an Update on the Proposed Joint Venture Between Gold Fields' Tarkwa Mine and AngloGold Ashanti's Iduapriem Mine in Ghana
LONDON & DENVER & JOHANNESBURG--(BUSINESS WIRE)--Gold Fields and AngloGold Ashanti (the “Parties”) refer shareholders to their joint media release of 16 March 2023 in which the Parties announced that they had agreed key terms for a proposed joint venture between...
CEOs of Gauzy and Research Frontiers Participate in Joint Interview with Benzinga All Access
Eyal Peso (GAUZ) and Joseph Harary (REFR) discuss the companies' partnership, the recent announcement about Ferrari's use of Suspended Particle Device (SPD) technology and future projects using SPD Interview now available and can be viewed at this link NEW YORK...
Helium Evolution Provides Well Results and Announces Partner to Drill Additional Joint Well
CALGARY, Alberta, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Helium Evolution Incorporated (TSXV:HEVI) ("HEVI" or the "Company"), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, provides an update on its exploration activities, including the results of its...
Tutor Perini - O&G Joint Venture is the Apparent Selected Proposer for the New York City Borough-Based Jail System, Manhattan Facility
NEW YORK--(BUSINESS WIRE)-- #newaward--Tutor Perini Corporation (NYSE: TPC) (the “Company”), a leading civil, building and specialty construction company, announced today that the Company, in a joint venture with O&G Industries, Inc. (“O&G”), has been identified as the Apparent Selected Proposer...
BluSky Carbon Joint Venture Inks Binding LOI's for Biochar Projects in Orlando and Tanzania
OLD SAYBROOK, CT and VANCOUVER, BC / ACCESSWIRE / November 6, 2024 / BluSky Carbon Inc. (CSE:BSKY)(OTCQB:BSKCF)(FWB:QE4/ WKN:A401NM) ("BluSky" or the "Company"), an innovative entry into the carbon removal clean technology sector, is pleased to announce that its recent joint...
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Joint Stock Company Kaspi.kz AO for potential violations of federal securities laws
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK , Nov. 4, 2024 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating potential securities claims on...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kz - KSPI
NEW YORK , Nov. 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi" or the "Company") (NASDAQ: KSPI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Rosen Law Firm Encourages Joint Stock Company Kaspi.kz Investors to Inquire About Securities Class Action Investigation - KSPI
NEW YORK , Nov. 1, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) resulting from allegations that Kaspi.kz...
Source: https://incomestatements.info
Category: Stock Reports